Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Depreciation and Depletion (2018 - 2025)

Historic Depreciation and Depletion for Sanara MedTech (SMTI) over the last 8 years, with Q3 2025 value amounting to $41557.0.

  • Sanara MedTech's Depreciation and Depletion fell 6793.24% to $41557.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $768790.0, marking a year-over-year increase of 4806.12%. This contributed to the annual value of $1.0 million for FY2024, which is 12613.49% up from last year.
  • According to the latest figures from Q3 2025, Sanara MedTech's Depreciation and Depletion is $41557.0, which was down 6793.24% from $45350.0 recorded in Q2 2025.
  • Sanara MedTech's 5-year Depreciation and Depletion high stood at $635625.0 for Q4 2024, and its period low was $17488.0 during Q1 2021.
  • In the last 5 years, Sanara MedTech's Depreciation and Depletion had a median value of $106347.0 in 2022 and averaged $118375.3.
  • In the last 5 years, Sanara MedTech's Depreciation and Depletion skyrocketed by 47876.03% in 2022 and then tumbled by 6793.24% in 2025.
  • Quarter analysis of 5 years shows Sanara MedTech's Depreciation and Depletion stood at $93123.0 in 2021, then increased by 15.02% to $107114.0 in 2022, then grew by 15.18% to $123376.0 in 2023, then surged by 415.19% to $635625.0 in 2024, then crashed by 93.46% to $41557.0 in 2025.
  • Its Depreciation and Depletion stands at $41557.0 for Q3 2025, versus $45350.0 for Q2 2025 and $46258.0 for Q1 2025.